LDS/Medical Tests/Biopsy, Bile Duct

Biopsy, Bile Duct

Bile duct biopsy is a procedure in which a small amount of the biliary tract tissue is removed for pathologic examination. The procedure can be done either via endoscopic retrograde cholangiopancreatography (ERCP) or during a percutaneous transhepatic cholangiogram (PTCA). It is generally performed as an outpatient procedure under local anesthesia. The sample can be procured as brushing/fine needle aspiration cytology (ERCP), endoscopic forceps biopsy (ERCP) or needle biopsy (PTCA). It is an invasive procedure but generally safe. Potential risks include bleeding at the biopsy site or infection; however, their incidence of both is very low. The bile duct biopsy is used for diagnosis of primary sclerosing cholangitis, biliary intraepithelial neoplasm, and cholangiocarcinoma.

Most common bile duct cancers are cholangiocarcinoma (CCA) and intraductal papillary cancer (IPC). CCA is the most common primary biliary malignancy and has a poor prognosis. IPC is a variant of bile duct carcinoma that is characterized by intraductal growth and better outcomes compared with common cholangiocarcinoma. Several intraductal neoplasms of the bile duct, particularly at a pre-invasive stage, have been recognized; including intraductal papillary neoplasm of the bile duct (IPNB), biliary intraepithelial neoplasm (BilIN), and intraductal tubulopapillary neoplasm (ITPN) of the bile duct. The diagnosis of bile duct cancer is usually done by biopsy; however, other markers (CA19-9, CEA and AFP) and genetic testing can be supportive.

  • Diagnosis of various biliary benign and malignant neoplasms (primary sclerosing cholangitis, biliary intraepithelial neoplasm, cholangiocarcinoma, metastases)
  • Diagnosis of various biliary diseases including chronic inflammatory/autoimmune conditions
Interpretation of the bile duct cytology/biopsy is dependent on the clinical presentation and pathologic findings. Clinical and radiologic data are important in the interpretation of the biopsy findings. Any abnormal morphologic findings are reported as supportive diagnosis. In addition, some special stains (IHC markers) can be used for staining to support findings.

There are no universal reference ranges for bile duct biopsies. In general, a normal bile duct biopsy consists of columnar mucosa and submucosal connective tissue.

Core biopsies are stained with hematoxylin and eosin, and various immunohistochemical stains at the discretion of the pathologist.

Biopsies and cytology samples are obtained by an interventional radiologist (PTCA) or a gastroenterologist (ERCP). Biopsy specimens are placed directly in formalin fixative. Cytology samples need to be placed in fixative solutions provided by the laboratory and vary depending on the commercial platforms used by the laboratory. Rarely, culture is indicated and tissue for culture should be sent in a sterile container to the laboratory for microbiological assessment.

Carcinogenic Antigen 19-9 (CA-19-9), Carcinoembryonic antigen (CEA), Alpha Fetoprotein (AFP), Hepatic Panel, CBC.
Usually 24 hours for routine light microscopy, longer for immunohistochemical stains, which varies from case to case.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login